Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: A comparative study

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 8, 1999, Pages 905-910

  Mahmood, Iftekhar ^a  

^a Woodmont Office Center II   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTISOMIDE; CEFPIRAMIDE; CIPROFLOXACIN; LATAMOXEF; PROCATEROL; TROGLITAZONE;

ARTICLE; BODY WEIGHT; BRAIN WEIGHT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; LIFESPAN; NONHUMAN; PHARMACOKINETICS; PREDICTION; SPECIES DIFFERENCE;

EID: 0032822442     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991773320     Document Type: Article

References (23)

1. Abadia, A. R., Aramayona, J. J., Munoz, M. J., Pladelfina, J. M., Saez, M. P., Bregante, M. A. (1994) Disposition of ciprofloxacin following intravenous administration in dogs. J. Vet. Pharmacol. Ther. 17: 384-388
2. Aramayona, J. J., Mora, J., Fraile, L. J., Garcia, M. A., Abadia, A. R., Bregante, M. A. (1996) Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. Am. J. Vet. Res. 57: 547-553
3. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J. Pharmacokin. Biopharm. 10: 201-227
4. Boxenbaum, H. (1984) Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug. Metab. Rev. 15: 1071-1021
5. Boxenbaum, H., Fertig, J. B. (1984) Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. Eur. J. Drug. Metab. Pharmacokin. 9: 177-183
6. Cook, C. S., Rozek, L. F., Stolzenbach, J., Anderson, S., Schoenhard, G. L., Karim, A. (1993) Pharmacokinetics of a novel antiarrhythmic drug, actisomide. Pharm. Res. 10: 427-433
7. Dedrick, R. L. (1973) Animal scale-up. J. Pharmacokin. Biopharm. 1: 435-461
8. Dedrick, R. L., Bischoff, K. B., Zaharko, D. Z. (1970) Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer. Chemother. Rep. (Part 1) 54: 95-101
9. Drusano, G. L., Plaisance, K. I. A., Standiford, H. C. (1986) Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob. Agents. Chemother. 30: 440-443
10. Eldon, M. A., Battle, M. M., Coon, M. J., Nordblom, G. D., Sedman, A. J., Colburn, W. A. (1993) Clinical pharmacokinetics and relative bioavailability of oral procaterol. Pharm. Res. 10: 603-605
11. Houston, J. B. (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47: 1469-1479
12. Ishigami, M., Sahuromaru, K., Niino, K., Kido, M., Morita, S., Miyamoto, G., Kohri, H. (1979) Pharmacokinetics of procaterol in the rat, rabbit and beagle dog. Arzneim. Forsch. 29: 266-270
13. Izumi, T., Enomoto, S., Hosiyama, K., Sasahara, K., Shibukawa, A., Nakagawa, T., Sugiyama, Y. (1996) Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach. J. Pharmacol. Exp. Ther. 277: 1630-1641
14. Mahmood, I., Balian, J. D. (1996a) Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in man from animals with special emphasis on clearance. J. Pharm. Sci. 85: 411-414
15. Mahmood, I., Balian, J. D. (1996b) Interspecies scaling: predicting clearance of drugs in man. Three different approaches. Xenobiotica 26: 887-895
16. Matsui, H., Yano, K., Okuda, T. (1982) Pharmacokinetics of cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkey. Antimicrob. Agents Chemother. 22: 213-217
17. Mordenti, J. (1985) Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from human data. J. Pharm. Sci. 74: 1097-1099
18. Nakagawa, K., Koyama, M., Matsui, H., Ikeda, C., Yano, K., Nakatsuru, N., Yoshinaga, K., Noguchi, T. (1984) Pharmacokinetics of cefpiramide (SM-1652) in man. Antimicrob. Agents Chemother. 25: 221-225
19. Nouws, J. F. M., Mevius, D. J., Vree, T. B., Baars, A. M., Laurensen, J. (1988) Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Vet. Quarterly 10: 156-163
20. Sacher, G. (1959) In: Wolstenholme, G. E. W., O'Connor, M. (eds) CIBA Foundation Colloquia on Aging, Churchill, London, pp 115-133
21. Sugeno, K., Okabe, H., Tanaka, H., Norikura, R. (1980) Disposition of 6059-S in rats, dogs and monkeys. Chemotherapy 28 (Suppl. 7): 194-195
22. Swabb, E., Bonner, D. (1983) Prediction of aztreonam pharmacokinetics in man based on data from animals. J. Pharmacokinet. Biopharm. 11: 215-223
23. Yamada, H., Yoshida, T., Oguma, T., Kimura, Y., Tochino, Y., Kurihara, T., Nagatake, F. (1980) Clinical pharmacology of 6059-S in healthy volunteers. Chemotherapy 28 (Suppl. 7): 251-262